Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing
Background The rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection of such alterations requires a matched non-neoplastic sample for adequate filtering of non-somatic events such as germline polymorphisms. Non-neoplas...
Uložené v:
| Vydané v: | BMC medical genomics Ročník 9; číslo 1; s. 64 - 10 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
BioMed Central
19.10.2016
BioMed Central Ltd Springer Nature B.V BMC |
| Predmet: | |
| ISSN: | 1755-8794, 1755-8794 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background
The rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection of such alterations requires a matched non-neoplastic sample for adequate filtering of non-somatic events such as germline polymorphisms. Non-neoplastic tissue adjacent to the excised neoplasm is often used for this purpose as it is simultaneously collected and generally contains the same tissue type as the neoplasm. Following NGS analysis, we and others have frequently observed low-level somatic mutations in these non-neoplastic tissues, which may impose additional challenges to somatic mutation detection as it complicates germline variant filtering.
Methods
We hypothesized that the low-level somatic mutation observed in non-neoplastic tissues may be entirely or partially caused by inadvertent contamination by neoplastic cells during the surgical pathology gross assessment or tissue procurement process. To test this hypothesis, we applied a systematic protocol designed to collect multiple grossly non-neoplastic tissues using different methods surrounding each single neoplasm. The procedure was applied in two breast cancer lumpectomy specimens. In each case, all samples were first sequenced by whole-exome sequencing to identify somatic mutations in the neoplasm and determine their presence in the adjacent non-neoplastic tissues. We then generated ultra-deep coverage using targeted sequencing to assess the levels of contamination in non-neoplastic tissue samples collected under different conditions.
Results
Contamination levels in non-neoplastic tissues ranged up to 3.5 and 20.9 % respectively in the two cases tested, with consistent pattern correlated with the manner of grossing and procurement. By carefully controlling the conditions of various steps during this process, we were able to eliminate any detectable contamination in both patients.
Conclusion
The results demonstrated that the process of tissue procurement contributes to the level of contamination in non-neoplastic tissue, and contamination can be reduced to below detectable levels by using a carefully designed collection method. A standard protocol dedicated for acquiring adjacent non-neoplastic tissue that minimizes neoplasm contamination should be implemented for all somatic mutation detection studies. |
|---|---|
| AbstractList | Background
The rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection of such alterations requires a matched non-neoplastic sample for adequate filtering of non-somatic events such as germline polymorphisms. Non-neoplastic tissue adjacent to the excised neoplasm is often used for this purpose as it is simultaneously collected and generally contains the same tissue type as the neoplasm. Following NGS analysis, we and others have frequently observed low-level somatic mutations in these non-neoplastic tissues, which may impose additional challenges to somatic mutation detection as it complicates germline variant filtering.
Methods
We hypothesized that the low-level somatic mutation observed in non-neoplastic tissues may be entirely or partially caused by inadvertent contamination by neoplastic cells during the surgical pathology gross assessment or tissue procurement process. To test this hypothesis, we applied a systematic protocol designed to collect multiple grossly non-neoplastic tissues using different methods surrounding each single neoplasm. The procedure was applied in two breast cancer lumpectomy specimens. In each case, all samples were first sequenced by whole-exome sequencing to identify somatic mutations in the neoplasm and determine their presence in the adjacent non-neoplastic tissues. We then generated ultra-deep coverage using targeted sequencing to assess the levels of contamination in non-neoplastic tissue samples collected under different conditions.
Results
Contamination levels in non-neoplastic tissues ranged up to 3.5 and 20.9 % respectively in the two cases tested, with consistent pattern correlated with the manner of grossing and procurement. By carefully controlling the conditions of various steps during this process, we were able to eliminate any detectable contamination in both patients.
Conclusion
The results demonstrated that the process of tissue procurement contributes to the level of contamination in non-neoplastic tissue, and contamination can be reduced to below detectable levels by using a carefully designed collection method. A standard protocol dedicated for acquiring adjacent non-neoplastic tissue that minimizes neoplasm contamination should be implemented for all somatic mutation detection studies. The rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection of such alterations requires a matched non-neoplastic sample for adequate filtering of non-somatic events such as germline polymorphisms. Non-neoplastic tissue adjacent to the excised neoplasm is often used for this purpose as it is simultaneously collected and generally contains the same tissue type as the neoplasm. Following NGS analysis, we and others have frequently observed low-level somatic mutations in these non-neoplastic tissues, which may impose additional challenges to somatic mutation detection as it complicates germline variant filtering. We hypothesized that the low-level somatic mutation observed in non-neoplastic tissues may be entirely or partially caused by inadvertent contamination by neoplastic cells during the surgical pathology gross assessment or tissue procurement process. To test this hypothesis, we applied a systematic protocol designed to collect multiple grossly non-neoplastic tissues using different methods surrounding each single neoplasm. The procedure was applied in two breast cancer lumpectomy specimens. In each case, all samples were first sequenced by whole-exome sequencing to identify somatic mutations in the neoplasm and determine their presence in the adjacent non-neoplastic tissues. We then generated ultra-deep coverage using targeted sequencing to assess the levels of contamination in non-neoplastic tissue samples collected under different conditions. Contamination levels in non-neoplastic tissues ranged up to 3.5 and 20.9 % respectively in the two cases tested, with consistent pattern correlated with the manner of grossing and procurement. By carefully controlling the conditions of various steps during this process, we were able to eliminate any detectable contamination in both patients. The results demonstrated that the process of tissue procurement contributes to the level of contamination in non-neoplastic tissue, and contamination can be reduced to below detectable levels by using a carefully designed collection method. A standard protocol dedicated for acquiring adjacent non-neoplastic tissue that minimizes neoplasm contamination should be implemented for all somatic mutation detection studies. The rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection of such alterations requires a matched non-neoplastic sample for adequate filtering of non-somatic events such as germline polymorphisms. Non-neoplastic tissue adjacent to the excised neoplasm is often used for this purpose as it is simultaneously collected and generally contains the same tissue type as the neoplasm. Following NGS analysis, we and others have frequently observed low-level somatic mutations in these non-neoplastic tissues, which may impose additional challenges to somatic mutation detection as it complicates germline variant filtering.BACKGROUNDThe rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection of such alterations requires a matched non-neoplastic sample for adequate filtering of non-somatic events such as germline polymorphisms. Non-neoplastic tissue adjacent to the excised neoplasm is often used for this purpose as it is simultaneously collected and generally contains the same tissue type as the neoplasm. Following NGS analysis, we and others have frequently observed low-level somatic mutations in these non-neoplastic tissues, which may impose additional challenges to somatic mutation detection as it complicates germline variant filtering.We hypothesized that the low-level somatic mutation observed in non-neoplastic tissues may be entirely or partially caused by inadvertent contamination by neoplastic cells during the surgical pathology gross assessment or tissue procurement process. To test this hypothesis, we applied a systematic protocol designed to collect multiple grossly non-neoplastic tissues using different methods surrounding each single neoplasm. The procedure was applied in two breast cancer lumpectomy specimens. In each case, all samples were first sequenced by whole-exome sequencing to identify somatic mutations in the neoplasm and determine their presence in the adjacent non-neoplastic tissues. We then generated ultra-deep coverage using targeted sequencing to assess the levels of contamination in non-neoplastic tissue samples collected under different conditions.METHODSWe hypothesized that the low-level somatic mutation observed in non-neoplastic tissues may be entirely or partially caused by inadvertent contamination by neoplastic cells during the surgical pathology gross assessment or tissue procurement process. To test this hypothesis, we applied a systematic protocol designed to collect multiple grossly non-neoplastic tissues using different methods surrounding each single neoplasm. The procedure was applied in two breast cancer lumpectomy specimens. In each case, all samples were first sequenced by whole-exome sequencing to identify somatic mutations in the neoplasm and determine their presence in the adjacent non-neoplastic tissues. We then generated ultra-deep coverage using targeted sequencing to assess the levels of contamination in non-neoplastic tissue samples collected under different conditions.Contamination levels in non-neoplastic tissues ranged up to 3.5 and 20.9 % respectively in the two cases tested, with consistent pattern correlated with the manner of grossing and procurement. By carefully controlling the conditions of various steps during this process, we were able to eliminate any detectable contamination in both patients.RESULTSContamination levels in non-neoplastic tissues ranged up to 3.5 and 20.9 % respectively in the two cases tested, with consistent pattern correlated with the manner of grossing and procurement. By carefully controlling the conditions of various steps during this process, we were able to eliminate any detectable contamination in both patients.The results demonstrated that the process of tissue procurement contributes to the level of contamination in non-neoplastic tissue, and contamination can be reduced to below detectable levels by using a carefully designed collection method. A standard protocol dedicated for acquiring adjacent non-neoplastic tissue that minimizes neoplasm contamination should be implemented for all somatic mutation detection studies.CONCLUSIONThe results demonstrated that the process of tissue procurement contributes to the level of contamination in non-neoplastic tissue, and contamination can be reduced to below detectable levels by using a carefully designed collection method. A standard protocol dedicated for acquiring adjacent non-neoplastic tissue that minimizes neoplasm contamination should be implemented for all somatic mutation detection studies. Abstract Background The rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection of such alterations requires a matched non-neoplastic sample for adequate filtering of non-somatic events such as germline polymorphisms. Non-neoplastic tissue adjacent to the excised neoplasm is often used for this purpose as it is simultaneously collected and generally contains the same tissue type as the neoplasm. Following NGS analysis, we and others have frequently observed low-level somatic mutations in these non-neoplastic tissues, which may impose additional challenges to somatic mutation detection as it complicates germline variant filtering. Methods We hypothesized that the low-level somatic mutation observed in non-neoplastic tissues may be entirely or partially caused by inadvertent contamination by neoplastic cells during the surgical pathology gross assessment or tissue procurement process. To test this hypothesis, we applied a systematic protocol designed to collect multiple grossly non-neoplastic tissues using different methods surrounding each single neoplasm. The procedure was applied in two breast cancer lumpectomy specimens. In each case, all samples were first sequenced by whole-exome sequencing to identify somatic mutations in the neoplasm and determine their presence in the adjacent non-neoplastic tissues. We then generated ultra-deep coverage using targeted sequencing to assess the levels of contamination in non-neoplastic tissue samples collected under different conditions. Results Contamination levels in non-neoplastic tissues ranged up to 3.5 and 20.9 % respectively in the two cases tested, with consistent pattern correlated with the manner of grossing and procurement. By carefully controlling the conditions of various steps during this process, we were able to eliminate any detectable contamination in both patients. Conclusion The results demonstrated that the process of tissue procurement contributes to the level of contamination in non-neoplastic tissue, and contamination can be reduced to below detectable levels by using a carefully designed collection method. A standard protocol dedicated for acquiring adjacent non-neoplastic tissue that minimizes neoplasm contamination should be implemented for all somatic mutation detection studies. Background The rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection of such alterations requires a matched non-neoplastic sample for adequate filtering of non-somatic events such as germline polymorphisms. Non-neoplastic tissue adjacent to the excised neoplasm is often used for this purpose as it is simultaneously collected and generally contains the same tissue type as the neoplasm. Following NGS analysis, we and others have frequently observed low-level somatic mutations in these non-neoplastic tissues, which may impose additional challenges to somatic mutation detection as it complicates germline variant filtering. Methods We hypothesized that the low-level somatic mutation observed in non-neoplastic tissues may be entirely or partially caused by inadvertent contamination by neoplastic cells during the surgical pathology gross assessment or tissue procurement process. To test this hypothesis, we applied a systematic protocol designed to collect multiple grossly non-neoplastic tissues using different methods surrounding each single neoplasm. The procedure was applied in two breast cancer lumpectomy specimens. In each case, all samples were first sequenced by whole-exome sequencing to identify somatic mutations in the neoplasm and determine their presence in the adjacent non-neoplastic tissues. We then generated ultra-deep coverage using targeted sequencing to assess the levels of contamination in non-neoplastic tissue samples collected under different conditions. Results Contamination levels in non-neoplastic tissues ranged up to 3.5 and 20.9 % respectively in the two cases tested, with consistent pattern correlated with the manner of grossing and procurement. By carefully controlling the conditions of various steps during this process, we were able to eliminate any detectable contamination in both patients. Conclusion The results demonstrated that the process of tissue procurement contributes to the level of contamination in non-neoplastic tissue, and contamination can be reduced to below detectable levels by using a carefully designed collection method. A standard protocol dedicated for acquiring adjacent non-neoplastic tissue that minimizes neoplasm contamination should be implemented for all somatic mutation detection studies. |
| ArticleNumber | 64 |
| Audience | Academic |
| Author | Papanicolau-Sengos, Antonios Glenn, Sean T. Liu, Song Wei, Lei Qin, Maochun Conroy, Jeffrey M. Morrison, Carl D. Krolewski, John Trump, Donald L. Miles, Kiersten Marie Johnson, Candace S. Omilian, Angela R. Brese, Elizabeth Wang, Jianmin Head, Karen Bshara, Wiam Hu, Qiang Burgher, Blake |
| Author_xml | – sequence: 1 givenname: Lei orcidid: 0000-0002-1881-8666 surname: Wei fullname: Wei, Lei email: Lei.Wei@RoswellPark.org organization: Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute – sequence: 2 givenname: Antonios surname: Papanicolau-Sengos fullname: Papanicolau-Sengos, Antonios organization: Center for Personalized Medicine, Roswell Park Cancer Institute – sequence: 3 givenname: Song surname: Liu fullname: Liu, Song organization: Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute – sequence: 4 givenname: Jianmin surname: Wang fullname: Wang, Jianmin organization: Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute – sequence: 5 givenname: Jeffrey M. surname: Conroy fullname: Conroy, Jeffrey M. organization: Center for Personalized Medicine, Roswell Park Cancer Institute – sequence: 6 givenname: Sean T. surname: Glenn fullname: Glenn, Sean T. organization: Department of Cancer Genetics, Roswell Park Cancer Institute – sequence: 7 givenname: Elizabeth surname: Brese fullname: Brese, Elizabeth organization: Department of Pathology, Roswell Park Cancer Institute – sequence: 8 givenname: Qiang surname: Hu fullname: Hu, Qiang organization: Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute – sequence: 9 givenname: Kiersten Marie surname: Miles fullname: Miles, Kiersten Marie organization: Center for Personalized Medicine, Roswell Park Cancer Institute – sequence: 10 givenname: Blake surname: Burgher fullname: Burgher, Blake organization: Center for Personalized Medicine, Roswell Park Cancer Institute – sequence: 11 givenname: Maochun surname: Qin fullname: Qin, Maochun organization: Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute – sequence: 12 givenname: Karen surname: Head fullname: Head, Karen organization: Department of Pathology, Roswell Park Cancer Institute – sequence: 13 givenname: Angela R. surname: Omilian fullname: Omilian, Angela R. organization: Department of Pathology, Roswell Park Cancer Institute – sequence: 14 givenname: Wiam surname: Bshara fullname: Bshara, Wiam organization: Department of Pathology, Roswell Park Cancer Institute – sequence: 15 givenname: John surname: Krolewski fullname: Krolewski, John organization: Center for Personalized Medicine, Roswell Park Cancer Institute – sequence: 16 givenname: Donald L. surname: Trump fullname: Trump, Donald L. organization: Department of Medicine, Roswell Park Cancer Institute, Inova Dwight & Martha Schar Cancer Institute – sequence: 17 givenname: Candace S. surname: Johnson fullname: Johnson, Candace S. organization: Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute – sequence: 18 givenname: Carl D. surname: Morrison fullname: Morrison, Carl D. email: Carl.Morrison@RoswellPark.org organization: Center for Personalized Medicine, Roswell Park Cancer Institute |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27756300$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UsuO1DAQjNAi9gEfwAVF4gKHLHYcP3JBWq14jLQSiMfZcpxO8CixBztZMQf-nR6yjGZWgHKw1V1V7a7UeXbig4cse0rJJaVKvEq0rEtSECoKUpaioA-yMyo5L5Ssq5OD-2l2ntKaEEF4TR9lp6WUXDBCzrKfH93UmWFIeehyN25i2EActjle7ByhzU27Nhb8lOPswkPYDCZNzuaTS2mGvAsxT2E0u9I4T3gGnxtvhm1yKZ-T833u4cdU9OAhLu0E32fwFluPs4c4PMGTu_Mi-_r2zZfr98XNh3er66ubwgomp0LITvJGNS2VNbesgbbltJMgcAfTgjJEGqIq2jW04sxKaxplK1EbpRpRcmAX2WrRbYNZ6010o4lbHYzTvwsh9tpEXGEA3QiF5LYGysqKClaXtQRmFXAiGWclar1etDZzM0K78yaa4Uj0uOPdN92HW40ChNQSBV7cCcSARqRJjy5ZGAaD9s5JU8V4VTMmFEKf34OuwxzR3QWF-zME7lG9wQWc7wLOtTtRfVVJwlVdV7t3X_4FhV8Lo7MYrM5h_Yjw8oiAmAn_ZG_mlPTq86dj7LNDU_Zu_AkaAugCsDGkFKHbQyjRuzDrJcwaw6x3YdYUOfIex7olYfhyN_yXWS7MhFN8D_HAt3-SfgGcjgih |
| CitedBy_id | crossref_primary_10_3390_cancers11081142 crossref_primary_10_3389_fimmu_2017_01807 crossref_primary_10_1038_s41592_018_0036_9 crossref_primary_10_1038_labinvest_2017_73 crossref_primary_10_3390_cancers13020205 crossref_primary_10_3389_fonc_2019_00119 |
| Cites_doi | 10.1038/nature11404 10.1186/gm495 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q 10.1136/jclinpath-2014-202404 10.1016/j.ygeno.2013.11.003 10.1172/JCI119748 10.1093/bioinformatics/btr446 10.1038/nature12634 10.1038/nature07423 10.1038/nature07385 10.1038/nbt.2514 10.1093/nar/gkq603 10.1007/s10549-012-2290-3 10.1016/j.yexmp.2012.10.018 10.1038/nature12965 10.1038/nature11903 10.1093/bioinformatics/btu376 10.1126/scitranslmed.aaa7161 10.1309/AJCP4FFSBPHAU8IU 10.1126/science.1204040 10.1038/ncomms10001 10.1016/j.humpath.2012.09.022 10.1126/science.aaa6806 10.1002/ijc.21815 10.1093/bioinformatics/btr032 10.1093/bioinformatics/btp324 10.1158/1055-9965.EPI-15-0205 10.1101/gr.187823.114 |
| ContentType | Journal Article |
| Copyright | The Author(s). 2016 COPYRIGHT 2016 BioMed Central Ltd. Copyright BioMed Central 2016 |
| Copyright_xml | – notice: The Author(s). 2016 – notice: COPYRIGHT 2016 BioMed Central Ltd. – notice: Copyright BioMed Central 2016 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7X7 7XB 88E 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 5PM DOA |
| DOI | 10.1186/s12920-016-0226-1 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection (UHCL Subscription) Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Databases ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1755-8794 |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_b68b8cd9e13241639297e3c8e5073532 PMC5070097 4237369781 A470589942 27756300 10_1186_s12920_016_0226_1 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: The Roswell Park Alliance Foundation – fundername: NCI NIH HHS grantid: P30 CA016056 – fundername: ; |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 7X7 88E 8AO 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EJD EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR INH INR ISR ITC KQ8 LK8 M1P M48 M7P M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D ~8M AAYXX AFFHD CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ K9. P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM |
| ID | FETCH-LOGICAL-c637t-67f75b8bd1795c3bedd51f7e6630ade8a07a0841fb1453c7cab8c469a88b625e3 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 8 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000386085000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1755-8794 |
| IngestDate | Mon Nov 10 04:34:36 EST 2025 Tue Nov 04 01:57:46 EST 2025 Thu Oct 02 11:45:49 EDT 2025 Tue Oct 07 05:30:36 EDT 2025 Tue Nov 11 10:58:13 EST 2025 Tue Nov 04 18:30:35 EST 2025 Thu Nov 13 16:35:58 EST 2025 Thu Jan 02 23:12:00 EST 2025 Sat Nov 29 04:11:59 EST 2025 Tue Nov 18 22:20:26 EST 2025 Sat Sep 06 07:29:04 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Somatic mutations Tumor contamination Adjacent normal tissues |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c637t-67f75b8bd1795c3bedd51f7e6630ade8a07a0841fb1453c7cab8c469a88b625e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-1881-8666 |
| OpenAccessLink | https://www.proquest.com/docview/1835663393?pq-origsite=%requestingapplication% |
| PMID | 27756300 |
| PQID | 1835663393 |
| PQPubID | 55237 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_b68b8cd9e13241639297e3c8e5073532 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5070097 proquest_miscellaneous_1835493368 proquest_journals_1835663393 gale_infotracmisc_A470589942 gale_infotracacademiconefile_A470589942 gale_incontextgauss_ISR_A470589942 pubmed_primary_27756300 crossref_primary_10_1186_s12920_016_0226_1 crossref_citationtrail_10_1186_s12920_016_0226_1 springer_journals_10_1186_s12920_016_0226_1 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-10-19 |
| PublicationDateYYYYMMDD | 2016-10-19 |
| PublicationDate_xml | – month: 10 year: 2016 text: 2016-10-19 day: 19 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationSubtitle | BMC series – open, inclusive and trusted |
| PublicationTitle | BMC medical genomics |
| PublicationTitleAbbrev | BMC Med Genomics |
| PublicationTitleAlternate | BMC Med Genomics |
| PublicationYear | 2016 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | AG Rivenbark (226_CR17) 2012; 93 CM Heaphy (226_CR16) 2006; 119 Cancer Genome Atlas Research N (226_CR6) 2012; 489 Cancer Genome Atlas Research N (226_CR4) 2008; 455 K Cibulskis (226_CR30) 2013; 31 LE Mose (226_CR26) 2014; 30 MP Foschini (226_CR18) 2013; 44 IA Cree (226_CR25) 2014; 67 LJ Prevo (226_CR15) 1999; 59 MN Edmonson (226_CR23) 2011; 27 LA Forsberg (226_CR28) 2015; 25 S Jones (226_CR2) 2015; 7 TS Alioto (226_CR31) 2015; 6 Q Zhu (226_CR9) 2015; 24 I Martincorena (226_CR20) 2015; 348 K Wang (226_CR24) 2010; 38 LJ Layfield (226_CR27) 2011; 136 K Cibulskis (226_CR29) 2011; 27 T Takahashi (226_CR14) 1998; 58 H Chai (226_CR12) 2009; 39 L Ding (226_CR3) 2008; 455 C Kandoth (226_CR7) 2013; 502 H Li (226_CR22) 2009; 25 WA Franklin (226_CR13) 1997; 100 MR Stratton (226_CR1) 2011; 331 A Sadanandam (226_CR21) 2012; 136 Network TCGAR (226_CR5) 2013; 494 The Cancer Genome Atlas Research N (226_CR8) 2014; 507 Q Wang (226_CR10) 2013; 5 DP Slaughter (226_CR11) 1953; 6 L Hawthorn (226_CR19) 2014; 103 19451168 - Bioinformatics. 2009 Jul 15;25(14):1754-60 23142414 - Exp Mol Pathol. 2012 Dec;93(3):391-8 9329980 - J Clin Invest. 1997 Oct 15;100(8):2133-7 23389443 - Nature. 2013 Feb 6;494(7438):506 26430163 - Genome Res. 2015 Oct;25(10):1521-35 16450377 - Int J Cancer. 2006 Jul 1;119(1):108-16 24132290 - Nature. 2013 Oct 17;502(7471):333-9 18948947 - Nature. 2008 Oct 23;455(7216):1069-75 25877891 - Sci Transl Med. 2015 Apr 15;7(283):283ra53 24476821 - Nature. 2014 Mar 20;507(7492):315-22 23337025 - Hum Pathol. 2013 Jul;44(7):1310-9 20601685 - Nucleic Acids Res. 2010 Sep;38(16):e164 13094644 - Cancer. 1953 Sep;6(5):963-8 22960745 - Nature. 2012 Sep 27;489(7417):519-25 21278191 - Bioinformatics. 2011 Mar 15;27(6):865-6 22031316 - Am J Clin Pathol. 2011 Nov;136(5):767-72 26647970 - Nat Commun. 2015 Dec 09;6:10001 18772890 - Nature. 2008 Oct 23;455(7216):1061-8 23396013 - Nat Biotechnol. 2013 Mar;31(3):213-9 21436442 - Science. 2011 Mar 25;331(6024):1553-8 25012948 - J Clin Pathol. 2014 Nov;67(11):923-31 23104223 - Breast Cancer Res Treat. 2012 Dec;136(3):693-703 10519384 - Cancer Res. 1999 Oct 1;59(19):4784-7 19880759 - Ann Clin Lab Sci. 2009 Fall;39(4):331-7 24112718 - Genome Med. 2013 Oct 11;5(10):91 24907369 - Bioinformatics. 2014 Oct;30(19):2813-5 24316131 - Genomics. 2014 Feb-Mar;103(2-3):211-21 21803805 - Bioinformatics. 2011 Sep 15;27(18):2601-2 9865743 - Cancer Res. 1998 Dec 15;58(24):5835-41 25999502 - Science. 2015 May 22;348(6237):880-6 25990554 - Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1207-13 |
| References_xml | – volume: 489 start-page: 519 issue: 7417 year: 2012 ident: 226_CR6 publication-title: Nature doi: 10.1038/nature11404 – volume: 5 start-page: 91 issue: 10 year: 2013 ident: 226_CR10 publication-title: Genome Med doi: 10.1186/gm495 – volume: 6 start-page: 963 issue: 5 year: 1953 ident: 226_CR11 publication-title: Cancer doi: 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q – volume: 67 start-page: 923 issue: 11 year: 2014 ident: 226_CR25 publication-title: J Clin Pathol doi: 10.1136/jclinpath-2014-202404 – volume: 103 start-page: 211 issue: 2–3 year: 2014 ident: 226_CR19 publication-title: Genomics doi: 10.1016/j.ygeno.2013.11.003 – volume: 100 start-page: 2133 issue: 8 year: 1997 ident: 226_CR13 publication-title: J Clin Investig doi: 10.1172/JCI119748 – volume: 27 start-page: 2601 issue: 18 year: 2011 ident: 226_CR29 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr446 – volume: 502 start-page: 333 issue: 7471 year: 2013 ident: 226_CR7 publication-title: Nature doi: 10.1038/nature12634 – volume: 455 start-page: 1069 issue: 7216 year: 2008 ident: 226_CR3 publication-title: Nature doi: 10.1038/nature07423 – volume: 455 start-page: 1061 issue: 7216 year: 2008 ident: 226_CR4 publication-title: Nature doi: 10.1038/nature07385 – volume: 31 start-page: 213 issue: 3 year: 2013 ident: 226_CR30 publication-title: Nat Biotechnol doi: 10.1038/nbt.2514 – volume: 38 issue: 16 year: 2010 ident: 226_CR24 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkq603 – volume: 136 start-page: 693 issue: 3 year: 2012 ident: 226_CR21 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-012-2290-3 – volume: 93 start-page: 391 issue: 3 year: 2012 ident: 226_CR17 publication-title: Exp Mol Pathol doi: 10.1016/j.yexmp.2012.10.018 – volume: 507 start-page: 315 issue: 7492 year: 2014 ident: 226_CR8 publication-title: Nature doi: 10.1038/nature12965 – volume: 494 start-page: 506 issue: 7438 year: 2013 ident: 226_CR5 publication-title: Nature doi: 10.1038/nature11903 – volume: 58 start-page: 5835 issue: 24 year: 1998 ident: 226_CR14 publication-title: Cancer Res – volume: 30 start-page: 2813 issue: 19 year: 2014 ident: 226_CR26 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu376 – volume: 7 start-page: 283ra253 issue: 283 year: 2015 ident: 226_CR2 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aaa7161 – volume: 136 start-page: 767 issue: 5 year: 2011 ident: 226_CR27 publication-title: Am J Clin Pathol doi: 10.1309/AJCP4FFSBPHAU8IU – volume: 331 start-page: 1553 issue: 6024 year: 2011 ident: 226_CR1 publication-title: Science doi: 10.1126/science.1204040 – volume: 6 start-page: 10001 year: 2015 ident: 226_CR31 publication-title: Nat Commun doi: 10.1038/ncomms10001 – volume: 44 start-page: 1310 issue: 7 year: 2013 ident: 226_CR18 publication-title: Hum Pathol doi: 10.1016/j.humpath.2012.09.022 – volume: 59 start-page: 4784 issue: 19 year: 1999 ident: 226_CR15 publication-title: Cancer Res – volume: 348 start-page: 880 issue: 6237 year: 2015 ident: 226_CR20 publication-title: Science doi: 10.1126/science.aaa6806 – volume: 119 start-page: 108 issue: 1 year: 2006 ident: 226_CR16 publication-title: Int J Cancer doi: 10.1002/ijc.21815 – volume: 27 start-page: 865 issue: 6 year: 2011 ident: 226_CR23 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr032 – volume: 39 start-page: 331 issue: 4 year: 2009 ident: 226_CR12 publication-title: Annals of Clinical & Laboratory Science – volume: 25 start-page: 1754 issue: 14 year: 2009 ident: 226_CR22 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp324 – volume: 24 start-page: 1207 issue: 8 year: 2015 ident: 226_CR9 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-15-0205 – volume: 25 start-page: 1521 issue: 10 year: 2015 ident: 226_CR28 publication-title: Genome Res doi: 10.1101/gr.187823.114 – reference: 21278191 - Bioinformatics. 2011 Mar 15;27(6):865-6 – reference: 19880759 - Ann Clin Lab Sci. 2009 Fall;39(4):331-7 – reference: 25877891 - Sci Transl Med. 2015 Apr 15;7(283):283ra53 – reference: 16450377 - Int J Cancer. 2006 Jul 1;119(1):108-16 – reference: 23389443 - Nature. 2013 Feb 6;494(7438):506 – reference: 18772890 - Nature. 2008 Oct 23;455(7216):1061-8 – reference: 18948947 - Nature. 2008 Oct 23;455(7216):1069-75 – reference: 22960745 - Nature. 2012 Sep 27;489(7417):519-25 – reference: 24476821 - Nature. 2014 Mar 20;507(7492):315-22 – reference: 9865743 - Cancer Res. 1998 Dec 15;58(24):5835-41 – reference: 23396013 - Nat Biotechnol. 2013 Mar;31(3):213-9 – reference: 24907369 - Bioinformatics. 2014 Oct;30(19):2813-5 – reference: 25990554 - Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1207-13 – reference: 22031316 - Am J Clin Pathol. 2011 Nov;136(5):767-72 – reference: 20601685 - Nucleic Acids Res. 2010 Sep;38(16):e164 – reference: 21803805 - Bioinformatics. 2011 Sep 15;27(18):2601-2 – reference: 26430163 - Genome Res. 2015 Oct;25(10):1521-35 – reference: 23142414 - Exp Mol Pathol. 2012 Dec;93(3):391-8 – reference: 24132290 - Nature. 2013 Oct 17;502(7471):333-9 – reference: 9329980 - J Clin Invest. 1997 Oct 15;100(8):2133-7 – reference: 23104223 - Breast Cancer Res Treat. 2012 Dec;136(3):693-703 – reference: 26647970 - Nat Commun. 2015 Dec 09;6:10001 – reference: 23337025 - Hum Pathol. 2013 Jul;44(7):1310-9 – reference: 13094644 - Cancer. 1953 Sep;6(5):963-8 – reference: 24316131 - Genomics. 2014 Feb-Mar;103(2-3):211-21 – reference: 24112718 - Genome Med. 2013 Oct 11;5(10):91 – reference: 25012948 - J Clin Pathol. 2014 Nov;67(11):923-31 – reference: 25999502 - Science. 2015 May 22;348(6237):880-6 – reference: 19451168 - Bioinformatics. 2009 Jul 15;25(14):1754-60 – reference: 10519384 - Cancer Res. 1999 Oct 1;59(19):4784-7 – reference: 21436442 - Science. 2011 Mar 25;331(6024):1553-8 |
| SSID | ssj0060591 |
| Score | 2.1354787 |
| Snippet | Background
The rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection of such... The rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection of such alterations... Background The rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection of such... Abstract Background The rapid adoption of next-generation sequencing provides an efficient system for detecting somatic alterations in neoplasms. The detection... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 64 |
| SubjectTerms | Adjacent normal tissues Bioinformatic and algorithmical studies Biomedical and Life Sciences Biomedicine DNA Mutational Analysis DNA sequencing Gene Expression Gene mutations Genome, Human - genetics High-Throughput Nucleotide Sequencing Human Genetics Humans Methods Microarrays Mutation Neoplasms - genetics Nucleotide sequencing Physiological aspects Research Article Somatic mutations Tumor contamination |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fi9QwEA5yiPgi_rbeKVEEQSnXNmmSPp7ioaDH4Q-4t5Ckyd7K2j2223vzf3cmzS7bE_XF182UTWe-JDPNly-EvHCq5ryty7wMBcsBFFVuGiVyaSxXLRNGmHhQ-KM8OVFnZ83pzlVfyAkb5YFHxx1aoaxybeOhbMLkAZZz6ZlTHhIZVrM4-xay2RRT4xwMOXpTpj3MUonDvsRLmaBsRsJtJfJysgpFsf7fp-SdNekqX_LKpmlci45vk1spiaRHY-fvkGu-u0tufErb5PfIz9P5OpjFoqfLQOf42eACeZsUV6th5Vtq2u8G_4ZC8Z93SCI3qNdM1zEMFBJZ2i-jmCv9MYyb9dQk-RKKVPkZ7bBknkXR6ticONnQdJ98O3739e37PN2zkDvB5DoXMsjaKtvC4Kwds76F4AXpIRkpTOuVKaQpFC-DLXnNnHQGIgJltVHKQvnk2QOyB931jwj1snLe2lYFJbgtvfG8DYEFJ7ySlfcZKTZ-1y6JkONdGAsdixEl9BgqjcQzDJUuM_Jq-8jFqMDxN-M3GMytIYpnxx8AUjpBSv8LUhl5jlDQKI_RIf9mZoa-1x--fNZHXOI9jA0Ho5fJKCzhDZxJxxnAD6ioNbE8mFjC-HXT5g3idJo_eg0TLeTZjDUsI8-2zfgkcuIAF8NowxvGhMrIwxGg2_eupEThtyIjcgLdiWOmLd38PKqLgxPwcE9GXm9AvtOtP_n98f_w-z65WeEQRb5Qc0D21qvBPyHX3SWAf_U0DvBfgy9UBQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Springer Standard Collection dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9UwEA6yivji_VJdJYogKGXbpk3Sx1VcFHRZXJV9C0maHI8c2-X01Df_uzNpetiuF9DXZgLJZCaZ6Xz5QshTK6uybKo8zX3GUjCKItW15KnQppQN45rrcFH4nTg8lCcn9VG8x91PaPepJBl26uDWku_1OT6sBKkvgmYLnkLKc7FCshlM0Y8_T9svhOd1HsuXv-02O4ACT_-vu_GZ4-g8VPJcvTQcQwfX_msC18nVGHXS_dFMbpALrr1JLr-PdfVb5MfRcuP1atXTztMl_mc4RaAnxeNtWLuG6uarxsHRtmvTFlHnGgme6SasG4XIl_ZdYH-l34axuk915DuhiK1f0BZz7EVguQ7NEcQNTbfJp4PXH1-9SePDDKnlTGxSLryojDQNeHNlmXENrLYXDqKXTDdO6kzoTJa5N3lZMSusNtJCHq6lNJBvOXaH7MBw3T1CnSisM6aRXvLS5E67svGeecudFIVzCcmm1VI2spbj4xkrFbIXydWoVoVINVSryhPyfNvldKTs-JvwSzSBrSCybYcP3XqhovMqwyVMoKkdpO4YwEJIKRyz0kEwzSpWJOQJGpBCPo0WATsLPfS9env8Qe2XAh9urEsQehaFfAczsDrefwA9IAXXTHJ3JgkOb-fNk52quOH0CnZmCMwZq1lCHm-bsSeC6MAuhlGmrBnjMiF3R7PezrsQApnisoSImcHPFDNvaZdfAh05KAFvAyXkxWT2Z4b1J73f_yfpB-RKgX6DSKJ6l-xs1oN7SC7Z72Dl60fB_38CBZJYwQ priority: 102 providerName: Springer Nature |
| Title | Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing |
| URI | https://link.springer.com/article/10.1186/s12920-016-0226-1 https://www.ncbi.nlm.nih.gov/pubmed/27756300 https://www.proquest.com/docview/1835663393 https://www.proquest.com/docview/1835493368 https://pubmed.ncbi.nlm.nih.gov/PMC5070097 https://doaj.org/article/b68b8cd9e13241639297e3c8e5073532 |
| Volume | 9 |
| WOSCitedRecordID | wos000386085000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1755-8794 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0060591 issn: 1755-8794 databaseCode: RBZ dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1755-8794 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0060591 issn: 1755-8794 databaseCode: DOA dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1755-8794 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0060591 issn: 1755-8794 databaseCode: M~E dateStart: 20080101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1755-8794 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0060591 issn: 1755-8794 databaseCode: M7P dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1755-8794 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0060591 issn: 1755-8794 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1755-8794 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0060591 issn: 1755-8794 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1755-8794 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0060591 issn: 1755-8794 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: Springer Standard Collection customDbUrl: eissn: 1755-8794 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0060591 issn: 1755-8794 databaseCode: RSV dateStart: 20081201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Pb9MwFLZgQ4gLvweBURmEhASKlsSJ7ZzQhjYxiVVVB6icLMdxSlFJStNy43_nPcctyxC7cKnU-EWK7c_2e_bn7xHy0sgsTcssDuMqYiGAIgl1LnkodJHKknHNtbso_EEMh3IyyUd-w631tMrNnOgm6rIxuEd-ANADz4OxnL1d_AgxaxServoUGtfJLqbNRpyLyTbgAk89j_1JZiz5QRtjaiYInpF2m_Aw7q1FTrL_74n5wsp0mTV56ejUrUgnd_63LnfJbe-L0sMOPPfINVvfJzfP_Gn7A_JrNFtVej5vaVPRGe4-LJD-SXHRWy9tSXX5TeN30rqpwxq56Bpln-nK9SYFf5i2jdOEpd_X3Zk_1V4FhSLjfkprjLynTvvaFXtqNxQ9JJ9Ojj--ex_6dA2h4UysQi4qkRWyKGGMZ4YVtgQMVMJCTSNdWqkjoSOZxlURpxkzwuhCGojOtZQFRGGW7ZEd-Fz7mFArEmOLopSV5GkRW23TsqpYZbiVIrE2INGm45TxWuaYUmOuXEwjuer6WiF_DftaxQF5vX1l0Ql5XGV8hGjYGqIGt3vQLKfKD2lVcAkVKHMLAT26teBoCsuMtOBis4wlAXmBWFKoslEjjWeq122rTs_H6jAVmM4xT8HolTeqGqiB0f5WBLQDCnP1LPd7ljANmH7xBmvKT0Ot-gO0gDzfFuObSK0DXKw7mzRnjMuAPOoQvq13IgTqx0UBET3s9xqmX1LPvjqRcmgEvCMUkDebUXLhs_7V7k-ursRTcivB0YuEonyf7KyWa_uM3DA_AdbLgRv77lcOyO7R8XA0HrgtlgESekfwbHR6NvoC_8bnn38D2EhqmQ |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lj9MwELaWLgIuvB-BBQwCIYGiTeLEdg4ILY_VVttWFSzScjKO45SikpSmBXHgL_EbmcmjbBaxtz1wrSdRZvp5PGN_niHkkZFRGKaR7_qZx1wAReDqWHJX6CSUKeOa6-qi8ECMRvLwMB5vkF_tXRikVbY-sXLUaWFwj3wboAeRB2MxezH_6mLXKDxdbVto1LDYtz--Q8pWPu-_hv_3cRDsvjl4tec2XQVcw5lYulxkIkpkkgIUI8MSm8KnZsLCyz2dWqk9oT0Z-lnihxEzwuhEGkgitZQJJAuWwXvPkM0Q9PJ6ZHPcH44_tL4fcoPYb85Ofcm3Sx-bQUG6jkTfgLt-Z_WrmgT8vRQcWQuP8zSPHdZWa-Dupf_NepfJxSbapjv19LhCNmx-lZwbNnyCa-TneLrM9GxW0iKjU9xfmSPBleKyvlrYlOr0s0a70LzI3RzZ9hoLW9NlhVcKET8ti6rqLf2yqlkNVDd1XijeKZjQHPcWJlV172q4Ia_D0HXy_lSUv0F68Ln2FqFWBMYmSSozycPEt9qGaZaxzHArRWCtQ7wWKMo01dqxachMVVmb5KrGlkKGHmJL-Q55un5kXpcqOUn4JaJvLYhVxqsfisVENU5LJVyCAmlsfQi7IXCHUFpYZqSFJIJFLHDIQ8SuwjoiORKVJnpVlqr_7q3aCQU2rIxDEHrSCGUFaGB0c-8D7IClxzqSWx1JcHSmO9xiWzWOtlR_gO2QB-thfBLJg4CLVS0Txoxx6ZCb9Yxa6x0IgRXyPIeIzlzrGKY7kk8_VWXYwQh4C8ohz9pZeeSz_mX32ycrcZ-c3zsYDtSgP9q_Qy4E6DmQPhVvkd5ysbJ3yVnzDSC-uNd4Hko-nvZ0_Q3itsLZ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfQQBMvfDMCAwxCQgJFS-LEdh7HR8XEqKoN0N4s27FLUUmrpuWN_527xKmW8SEhXuuzZF_uznf1z78j5JmVRZ5XRRqnPmExGEUW61LyWGiTy4pxzXX7UPhYjMfy7KychD6nTY92768kuzcNyNJUrw-Wle9cXPKDJsUmS1AGI4A24zGUP5dzKGQQ03Vy-rkPxZCql2m4yvzttMFh1HL2_xqZzx1NF2GTF-5O2yNpdP2_N3ODXAvZKD3szOcmueTqW2T3Q7hvv01-TGZrr-fzhi48neH_D0sEgFI89jYrV1FdfdW4UFov6rhGNLpG4me6br8nhYyYNouWFZZ-23S3_lQHHhSKmPsprbH2nrbs1-1wAHfD0B3yafT24-t3cWjYEFvOxDrmwovCSFOBlxeWGVeBFXjhIKtJdOWkToROZJ56k-YFs8JqIy3U51pKA3WYY3fJDizX3SPUicw6YyrpJc9N6rTLK--Zt9xJkTkXkaT_csoGNnNsqjFXbVUjuerUqhDBhmpVaURebKcsOyqPvwm_QnPYCiILd_vDYjVVwamV4RI2UJUOSnpMbCHVFI5Z6SDJZgXLIvIUjUkhz0aNQJ6p3jSNOjo9UYe5wIaOZQ5Cz4OQX8AOrA7vIkAPSM01kNwfSEIgsMPh3mZVCESNgogNCTtjJYvIk-0wzkRwHdjFppPJS8a4jMheZ-LbfWdCIINcEhExMP6BYoYj9exLS1MOSsBXQhF52bvAuWX9Se_3_0n6MdmdvBmp46Px-wfkaoYuhGCjcp_srFcb95Bcsd_B4FeP2rDwE-uHZIk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pitfalls+of+improperly+procured+adjacent+non-neoplastic+tissue+for+somatic+mutation+analysis+using+next-generation+sequencing&rft.jtitle=BMC+medical+genomics&rft.au=Wei%2C+Lei&rft.au=Papanicolau-Sengos%2C+Antonios&rft.au=Liu%2C+Song&rft.au=Wang%2C+Jianmin&rft.date=2016-10-19&rft.issn=1755-8794&rft.eissn=1755-8794&rft.volume=9&rft.issue=1&rft_id=info:doi/10.1186%2Fs12920-016-0226-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12920_016_0226_1 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1755-8794&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1755-8794&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1755-8794&client=summon |